Related Experiment Video
Updated: Jun 12, 2026
07:24
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing
Anna Haywood1, Helene Dreau, Adele Timbs
1National Haemoglobinopathy Reference Laboratory, Molecular Haematology, Haemophilia Centre, Churchill Hospital, Oxford Radcliffe NHS Trust, Oxford, UK OX3 7LJ. anna.haywood@orh.nhs.uk
Annals of Hematology
|June 23, 2010
Summary
Non-deletional alpha-thalassaemia causes more severe health issues than deletional forms. Pyrosequencing offers a faster, cheaper, and more accurate method for detecting these mutations, improving diagnosis.
Area of Science:
- Medical Genetics
- Molecular Diagnostics
- Hematology
Background:
- Non-deletional alpha-thalassaemia presents higher morbidity and mortality risks compared to deletional forms.
- Current screening methods like Gap-PCR are effective for deletional alpha-thalassaemia but less so for non-deletional types.
- Detecting non-deletional alpha-thalassaemia is complex due to gene homology and co-existing deletional forms, necessitating advanced diagnostic approaches.
Purpose of the Study:
- To develop and validate a rapid, cost-effective screening method for common non-deletional alpha-thalassaemia mutations.
- To address the growing demand for efficient diagnostic technologies for non-deletional alpha-thalassaemia in the UK.
- To improve the accuracy and speed of diagnosing patients with suspected non-deletional alpha-thalassaemia and facilitate prenatal diagnosis.
Main Methods:
- Utilized pyrosequencing technology to detect ten common clinically significant non-deletional alpha-thalassaemia mutations.
- Applied the pyrosequencing method to screen 105 patients previously diagnosed with non-deletional alpha-thalassaemia.
- Compared pyrosequencing results against established genotypes determined by Sanger sequencing.
Main Results:
- Achieved 100% concordance between pyrosequencing results and known genotypes from Sanger sequencing.
- Demonstrated that pyrosequencing is simpler, more robust, quicker, and cheaper than conventional sequencing methods.
- Confirmed the effectiveness of pyrosequencing for accurate mutation detection in a clinical setting.
Conclusions:
- Pyrosequencing provides a superior alternative to conventional sequencing for the rapid and cost-effective diagnosis of non-deletional alpha-thalassaemia.
- This pyrosequencing method can significantly expedite the diagnosis of non-deletional alpha-thalassaemia, including prenatal diagnosis for at-risk pregnancies.
- The developed pyrosequencing assay offers a valuable tool for clinical laboratories managing patients with suspected alpha-thalassaemia mutations.
